Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

NCT05564416 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Feasibility issues

Conditions

Bladder Carcinoma
Bladder Urothelial Carcinoma
Muscle Invasive Bladder Carcinoma
Renal Pelvis and Ureter Urothelial Carcinoma
Stage II Bladder Cancer AJCC v8
Stage III Bladder Cancer AJCC v8
Stage IVA Bladder Cancer AJCC v8
Urothelial Carcinoma

Interventions

BIOLOGICAL: Atezolizumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Cystoscopy
DRUG: Erdafitinib
PROCEDURE: Magnetic Resonance Imaging

Sponsor

National Cancer Institute (NCI)